Another report showed that the plasma MMP-2 levels decreased while MMP-9 levels increased in severe COVID-19 patients, but the COVID-19 non-survivors had higher MMP-2 levels than COVID-19 survivors, which is considered to be related to the activation of the renin–angiotensin system [121]. This evidence concerns the gene MMP9 and COVID-19.